Assets mario has a different idea hell tell you what it is coming up. Excitement over tax reform is helping to fuel todays market gains, Murray Energy ceo whos been a supporter of the president s says the senate bill is, quote, a mockery of tax reform, and his companys taxes will go up under this plan hell explain and make his case. Then pancreatic cancer one of the most deadly forms of cancer out there former Nbc Universal chair bob wright will join us at post the, talk about his new rush to take on a new push. Hes rushing on this, too. Oh, yeah. Hoping they can get an Early Detection test out there on pancreatic cancer. Lets start with todays rally, though. Dow was up 300 early on, were about half that level right now. Bob pisani has more here bob . Good news, folks, we are acting rationally in the last five or six days so the sectors in the stocks that might see the biggest earnings boost from the tax cut are the ones that have been moving the most in the last five, six day. Its hap
Technology investors with these kinds of gains after stellar earnings last night . It was unbelievable. Weve got a story on that coming up in just a moment here. You guys had your hands full. It was a rollicking hour, i hear it was. Meantime, a rollicking deal through the health care space. Cvs is pursuing a major deal to buy aetna and former aetna ceo john rowe will join us in a cnbc exclusive to discuss what that bid could mean. What a fascinating story that is cant wait to talk to john about is. Also look at oil today, trading higher, brent is back to 60 a barrel and wti is at an eightmonth high however, chevron is falling. Whats behind the move and whether this is a buying opportunity or not well talk about that coming up in a little bit later. Is pretty sharp moves in oil today. Lets go back to the big rally in tech stocks, thanks to strong earnings from a trio of tech giants. Deirdre bosa is all over amazons results for us. Josh lipton covering alphabet. Jon fortt is covering mic
Saira Jan, PharmD, MS, of Horizon Blue Cross Blue Shield of New Jersey, discussed cost savings that occurred so far from their collaborative pilot program with Rutgers Cancer Institute of New Jersey and RWJ Barnabas Health and also noted those they predict to occur as the program continues.
- First quarter net sales of $16.1 million, up 4.2% year-over-year - - Submitted Supplemental Data to FDA for IND Application to enable Phase 2 FPC Home.
/PRNewswire/ CarepathRx, a leader in pharmacy and medication management solutions, announced a new home infusion pharmacy partnership with Allied Health.